Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer
Interventions: DRUG: Darbepoetin Alfa|DRUG: Pegfilgrastim|DRUG: Paclitaxel|DRUG: Doxorubicin|DRUG: Cyclophosphamide
Sponsor: Harold J. Burstein, MD, PhD
Collaborators: Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Lowell General Hospital|Brigham and Women's Hospital|North Shore Medical Center